Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines
The influenza A/H1N1 pandemic in 2009 taught us that the monitoring of vaccine benefits and risks in Europe had potential for improvement if different public and private stakeholders would collaborate better (public health institutes (PHIs), regulatory authorities, research institutes, vaccine manuf...
Main Authors: | Sturkenboom, M, Bahri, P, Chiucchiuini, A, Grove Krause, T, Hahné, S, Khromava, A, Kokki, M, Kramarz, P, Kurz, X, Larson, H, De Lusignan, S, Mahy, P, Torcel-Pagnon, L, Titievsky, L, Bauchau, V |
---|---|
Format: | Journal article |
Published: |
Elsevier
2019
|
Similar Items
-
Opportunities and challenges for near real time monitoring (NRTM) of vaccine exposures and outcomes in the participating databases of the ADVANCE consortium
by: Titievsky, L, et al.
Published: (2019) -
Determinants of shingles vaccine acceptance in the United Kingdom.
by: Hélène Bricout, et al.
Published: (2019-01-01) -
Understanding why Eritreans go to Europe
by: Brhane, M
Published: (2016) -
Understanding why Eritreans go to Europe
by: Mogos O Brhane
Published: (2016-01-01) -
Understanding why people participate in HIV surveillance
by: Basia Zaba, et al.
Published: (2015-05-01)